Daniel G. Fuster

4.1k total citations
94 papers, 2.1k citations indexed

About

Daniel G. Fuster is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Daniel G. Fuster has authored 94 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 40 papers in Pulmonary and Respiratory Medicine and 28 papers in Nephrology. Recurrent topics in Daniel G. Fuster's work include Kidney Stones and Urolithiasis Treatments (28 papers), Ion Transport and Channel Regulation (27 papers) and Parathyroid Disorders and Treatments (15 papers). Daniel G. Fuster is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (28 papers), Ion Transport and Channel Regulation (27 papers) and Parathyroid Disorders and Treatments (15 papers). Daniel G. Fuster collaborates with scholars based in Switzerland, United States and Italy. Daniel G. Fuster's co-authors include Orson W. Moe, R. Todd Alexander, Chung‐Ming Tse, Mark Donowitz, Manuel Anderegg, Donald W. Hilgemann, Alexandre Simonin, Bruno Vogt, Nasser A. Dhayat and I. Alexandru Bobulescu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Daniel G. Fuster

88 papers receiving 2.1k citations

Peers

Countries citing papers authored by Daniel G. Fuster

Since Specialization

Citations

This map shows the geographic impact of Daniel G. Fuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel G. Fuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel G. Fuster more than expected).

Fields of papers citing papers by Daniel G. Fuster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel G. Fuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel G. Fuster. The network helps show where Daniel G. Fuster may publish in the future.

Co-authorship network of co-authors of Daniel G. Fuster

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel G. Fuster. A scholar is included among the top collaborators of Daniel G. Fuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel G. Fuster. Daniel G. Fuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidental findings on non-contrast abdominal computed tomography in an asymptomatic population: Prevalence, economic and health implications 2025 ·PLoS ONE ·Alexander Ritter, (unknown), Olivier Bonny, Grégoire Wuerzner, Thomas Ernandez, (unknown), Stephan Segerer, Daniel G. Fuster, Beat Roth, Nilufar Mohebbi, Lena Jellestad, (unknown), Carsten A. Wagner, Harald Seeger	0
2	Indapamide or chlorthalidone to reduce urine supersaturation for secondary prevention of kidney stones: protocol for a randomised, double-blind, cross-over trial (INDAPACHLOR) 2025 ·BMJ Open ·(unknown), Matteo Bargagli, (unknown), Marie Roumet, Sven Trelle, Daniel G. Fuster	1
3	PIP2-mediated oligomerization of the endosomal sodium/proton exchanger NHE9 2025 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Giuseppe Albano, (unknown), Lucie Delemotte, Daniel G. Fuster, David Drew	5
4	Effects of thiazides and new findings on kidney stones and dysglycemic side effects 2024 ·Acta Physiologica ·Matteo Bargagli, Manuel Anderegg, Daniel G. Fuster	2
5	Risk Factors of Asymptomatic Kidney Stone Passage in Adults with Recurrent Kidney Stones 2024 ·Clinical Journal of the American Society of Nephrology ·(unknown), Daniel G. Fuster, Nasser A. Dhayat, Olivier Bonny, (unknown), Andreas Christe, Anas Taha, (unknown), (unknown), Beat Roth, (unknown)	2
6	Thiazides Attenuate Insulin Secretion Through Inhibition of Mitochondrial Carbonic Anhydrase 5b in β-Islet Cells in Mice 2023 ·Journal of the American Society of Nephrology ·(unknown), Giuseppe Albano, (unknown), (unknown), Matteo Bargagli, Manuel Anderegg, Stephan Wueest, Daniel Konrad, Daniel G. Fuster	6
7	Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort 2023 ·Journal of Renal Nutrition ·(unknown), (unknown), Jérôme Pasquier, Angéline Chatelan, Daniel G. Fuster, Nasser A. Dhayat, Harald Seeger, Alexander Ritter, Nilufar Mohebbi, Thomas Ernandez, (unknown), (unknown), Stephan Segerer, Grégoire Wuerzner, (unknown), Beat Roth, Carsten A. Wagner, Olivier Bonny, Murielle Bochud	11
8	Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass 2023 ·Diabetes Technology & Therapeutics ·(unknown), Katja A. Schönenberger, Natascha Potoczna, Andreas Vogt, Philipp A. Gerber, Jörg Zehetner, Daniel Giachino, Philipp C. Nett, Joanna Gawinecka, (unknown), Daniel G. Fuster, Chiara Dalla Man, Andrea Facchinetti, Andreas Melmer, Christos T. Nakas, Matthias Hepprich, Marc Y. Donath, David Herzig, Lia Bally	7
9	Discovery of novel gating checkpoints in the Orai1 calcium channel by systematic analysis of constitutively active mutants of its paralogs and orthologs 2022 ·Cell Calcium ·Bartłomiej Augustynek, Gergely Gyimesi, (unknown), (unknown), Giuseppe Albano, (unknown), Palanivel Kandasamy, (unknown), Irene Frischauf, Daniel G. Fuster, Christine Peinelt, Matthias A. Hediger, Rajesh Bhardwaj	3
10	Urinary tetrahydroaldosterone is associated with circulating FGF23 in kidney stone formers 2022 ·Urolithiasis ·Matthias B. Moor, Nasser A. Dhayat, (unknown), (unknown), Bruno Vogt, Daniel G. Fuster	2
11	The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease 2022 ·Journal of Nephrology ·Pietro Manuel Ferraro, Matteo Bargagli, (unknown), Manuel Anderegg, Uyen Huynh‐Do, Bruno Vogt, Giovanni Gambaro, Daniel G. Fuster	3
12	Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial 2022 ·BMJ Open ·(unknown), Lia Bally, Grazia M. Cereghetti, (unknown), Matthias B. Moor, Bruno Vogt, (unknown), Sven Trelle, Daniel G. Fuster	20
13	The Role of Diet in Bone and Mineral Metabolism and Secondary Hyperparathyroidism 2021 ·Nutrients ·Matteo Bargagli, Maria Arena, Alessandro Naticchia, Giovanni Gambaro, Sandro Mazzaferro, Daniel G. Fuster, Pietro Manuel Ferraro	11
14	Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients 2021 ·Kidney International Reports ·Matteo Bargagli, Pietro Manuel Ferraro, Nasser A. Dhayat, Manuel Anderegg, Daniel G. Fuster	2
15	Deletion of the sodium/hydrogen exchanger 6 causes low bone volume in adult mice 2021 ·Bone ·(unknown), Giuseppe Albano, (unknown), Silvia Dolder, Mark Siegrist, Manuel Anderegg, Ganesh Pathare, Willy Hofstetter, Roland Baron, Daniel G. Fuster	2
16	Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan 2020 ·Clinical Journal of the American Society of Nephrology ·Matteo Bargagli, Nasser A. Dhayat, Manuel Anderegg, Mariam Semmo, Uyen Huynh‐Do, Bruno Vogt, Pietro Manuel Ferraro, Daniel G. Fuster	16
17	Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content 2020 ·Urolithiasis ·Arman Tsaturyan, (unknown), (unknown), Olivier Bonny, Daniel G. Fuster, Beat Roth	32
18	Parathyroid Hormone and Plasma Phosphate Are Predictors of Soluble α-Klotho Levels in Adults of European Descent 2019 ·The Journal of Clinical Endocrinology & Metabolism ·Nasser A. Dhayat, Menno Pruijm, Belén Ponte, Daniel Ackermann, Alexander Leichtle, Olivier Devuyst, Georg Ehret, Idris Guessous, Antoinette Péchère-Bertschi, Johanne Pastor, Pierre‐Yves Martin, Michel Burnier, Martin Fiedler, Bruno Vogt, Orson W. Moe, Murielle Bochud, Daniel G. Fuster	7
19	Absceso de psoas asociado a infección de una artroplastia de cadera 2013 ·Revista española de quimioterapia. Suplemento ·(unknown), S. García-Ramiro, Guillem Bori, Xavier Gallart, (unknown), Daniel G. Fuster, José Mensa, Àlex Soriano	2
20	GABARAP deficiency modulates expression of NaPi-IIa in renal brush-border membranes 2009 ·American Journal of Physiology-Renal Physiology ·(unknown), Serge M. Gisler, Daniel G. Fuster, Orson W. Moe, Gregory A. O’Sullivan, Heinrich Betz, Jürg Biber, Heini Murer, Nati Hernando	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact